Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Premenstrual syndrome

R L Reid, S S Yen

    American Journal of Obstetrics and Gynecology
    |January 1, 1981
    PubMed
    Summary
    This summary is machine-generated.

    Premenstrual syndrome (PMS) may stem from luteal phase sensitivity and withdrawal from neuropeptides like beta-endorphin. This neuroendocrine dysfunction impacts mood, behavior, and hormone release, explaining PMS variability.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Hormone therapy and breast cancer: risk communication and the 'perfect storm'.

    Climacteric : the journal of the International Menopause Society·2018
    Same author

    Heavy menstrual bleeding: is tranexamic acid a safe adjunct to combined hormonal contraception?

    Contraception·2018
    Same author

    Randomized clinical trial of a handheld cooling device (Menopod®) for relief of menopausal vasomotor symptoms.

    Climacteric : the journal of the International Menopause Society·2015
    Same author

    The distribution of fluorine in potable waters in New South Wales and Tasmania.

    The Medical journal of Australia·2010
    Same author

    The effect of 2,3,7,8-tetrachlorodibenzo-p-dioxin on corticotrophin-releasing hormone, arginine vasopressin, and pro-opiomelanocortin mRNA levels in the hypothalamus of the cynomolgus monkey.

    Toxicological sciences : an official journal of the Society of Toxicology·2001
    Same author

    Menstrual cycle effects on common medical conditions.

    Comprehensive therapy·2001
    Same journal

    Likelihood ratios enhance clinical interpretation of metagenomic prediction of early-onset neonatal sepsis in preterm premature rupture of membranes (Letter-to-the-Editor).

    American journal of obstetrics and gynecology·2026
    Same journal

    Taking risk stratification in preterm premature rupture of membranes to the bedside (Reply to Letter-to-the-Editor).

    American journal of obstetrics and gynecology·2026
    Same journal

    Gestational Age at Full-Term Delivery and Long-Term Offspring Morbidity in Low-Risk Pregnancies: A Population-Based Cohort Study.

    American journal of obstetrics and gynecology·2026
    Same journal

    Trajectories of childbirth-related posttraumatic stress symptoms after a vaginal delivery: a multicenter prospective study.

    American journal of obstetrics and gynecology·2026
    Same journal

    Early life adversity and polycystic ovary syndrome among North American pregnancy planners.

    American journal of obstetrics and gynecology·2026
    Same journal

    Survival assessment of adjuvant chemotherapy for cytology-negative, non-myoinvasive stage IC clear cell endometrial cancer.

    American journal of obstetrics and gynecology·2026
    See all related articles

    Area of Science:

    • Neuroendocrinology
    • Psychoneuroimmunology

    Background:

    • Premenstrual syndrome (PMS) affects many women, but its exact cause remains unclear.
    • Current understanding is largely descriptive, lacking a defined etiology.
    • PMS is recognized as a complex psychoneuroendocrine dysfunction.

    Purpose of the Study:

    • To explore biochemical and psychosocial factors contributing to PMS.
    • To redefine the pathophysiology of premenstrual syndrome.
    • To propose a novel hypothesis for PMS etiology.

    Main Methods:

    • Literature review focusing on biochemical and psychosocial elements of PMS.
    • Exploration of neuropeptide roles in the central nervous system.
    • Analysis of neuroendocrine pathways involved in the brain-hypothalamus-pituitary complex.

    Related Experiment Videos

    Main Results:

    • Sensitivity to and withdrawal from beta-endorphin and alpha-melanocyte-stimulating hormone during the luteal phase are implicated.
    • These neuropeptides may modulate neurotransmitter function, affecting mood and behavior.
    • Proposed cascade involves altered pituitary release of prolactin and vasopressin.

    Conclusions:

    • PMS pathophysiology may involve luteal phase neuropeptide withdrawal.
    • Neuroendocrine changes within the brain-pituitary axis are central to PMS.
    • Individual variations in gonadal steroid modulation explain the diverse clinical presentations of PMS.